GLPMGRVictoza injection sites: what the manufacturer says
This page lists where the manufacturer says Victoza (liraglutide) can be injected in the UK, the EU and the US, in their own words, with the documents each list comes from. It is not medical advice.
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the heat map is your own record. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.
Where Victoza can be injected
Manufacturer: Novo Nordisk
United Kingdom
Areas listed:
- Front of waist (abdomen)
- Front of thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change the place where you inject each day to reduce the risk of developing lumps.”
Source: MHRA products database / Abacus Medicine Ltd: Victoza 6 mg/ml solution for injection in pre-filled pen, package leaflet (PL 45763/1340, last revised 11/02/2025), revised 11/02/2025. Checked 20 September 2026.
Also consulted:
- MHRA products database / Novo Nordisk A/S: Victoza 6 mg/ml solution for injection in pre-filled pen, Summary of Product Characteristics (PLGB 04668/0413, text revised 04/11/2024) — Lists the same three areas; no rotation wording.
- MHRA products database / Orifarm UK Ltd: Victoza 6 mg/ml pre-filled pen, package leaflet (PLGB 45985/0233, revision 16/10/2023) — An older parallel-import leaflet giving the same areas; no rotation sentence.
European Union
Areas listed:
- Abdomen
- Thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change the place where you inject each day to reduce the risk of developing lumps.”
Source: EMA: Victoza EPAR Product Information (English). Checked 20 September 2026.
Also consulted:
- EMA: Victoza: EPAR (European Public Assessment Report) page, listing the current product information and its last-updated date — Used to confirm the current English product information.
United States
Areas listed:
- Stomach (abdomen)
- Thigh
- Upper arm — another person should inject here
Rotation, in the manufacturer’s words: “Change (rotate) your injection site with each injection. Change (rotate) your injection sites within the area you choose for each dose.”
Source: FDA / DailyMed: Victoza prescribing information and patient instructions (DailyMed, current label), revised v31 (2025-10-14). Checked 20 September 2026.
Also consulted:
- Novo Nordisk: How to take Victoza (patient website, step by step) — Consumer summary; lists the same three areas but not the caregiver rule for the upper arm, so the full label is followed.
Track your Victoza injection sites in GLPMGR
GLPMGR is a private GLP-1 tracker for iPhone, iPad and Apple Watch. Choose Victoza when you record a dose and it offers only the areas above for your region, shows a body map of where you have injected before, and shows the manufacturer’s rotation wording. It does not tell you where to inject, and it is independent of Novo Nordisk.
Coming soon to the App Store
Other medicines with the same active ingredient:
Medical disclaimer
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the heat map is your own record. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.